Abstract: The present disclosure provides human CD33 antibodies and antibody glucocorticoid receptor agonist conjugates and methods of using the conjugates for the treatment of myeloid cell associated diseases.
| # | Name | Date |
|---|---|---|
| 1 | 202517005088-STATEMENT OF UNDERTAKING (FORM 3) [22-01-2025(online)].pdf | 2025-01-22 |
| 3 | 202517005088-Sequence Listing in PDF [22-01-2025(online)].pdf | 2025-01-22 |
| 4 | 202517005088-REQUEST FOR EXAMINATION (FORM-18) [22-01-2025(online)].pdf | 2025-01-22 |
| 5 | 202517005088-POWER OF AUTHORITY [22-01-2025(online)].pdf | 2025-01-22 |
| 6 | 202517005088-FORM-26 [22-01-2025(online)].pdf | 2025-01-22 |
| 7 | 202517005088-FORM 18 [22-01-2025(online)].pdf | 2025-01-22 |
| 8 | 202517005088-FORM 1 [22-01-2025(online)].pdf | 2025-01-22 |
| 9 | 202517005088-DRAWINGS [22-01-2025(online)].pdf | 2025-01-22 |
| 10 | 202517005088-DECLARATION OF INVENTORSHIP (FORM 5) [22-01-2025(online)].pdf | 2025-01-22 |
| 11 | 202517005088-COMPLETE SPECIFICATION [22-01-2025(online)].pdf | 2025-01-22 |
| 12 | 202517005088-CLAIMS UNDER RULE 1 (PROVISIO) OF RULE 20 [22-01-2025(online)].pdf | 2025-01-22 |
| 13 | 202517005088-FORM 3 [21-02-2025(online)].pdf | 2025-02-21 |
| 14 | 202517005088-Proof of Right [01-07-2025(online)].pdf | 2025-07-01 |